ABSTRACT
A major challenge for clinical management of melanoma is the prevention and treatment of metastatic disease. Drug discovery efforts over the last 10â years have resulted in several drugs that improve the prognosis of metastatic melanoma; however, most patients develop early resistance to these treatments. We designed and synthesized, through a concise synthetic strategy, a series of hybrid olefin-pyridinone compounds that consist of structural motifs from tamoxifen and ilicicolin H. These compounds were tested against a human melanoma cell line and patient-derived melanoma cells that had metastasized to the brain. Three compounds 7 b, 7 c, and 7 g demonstrated promising activity (IC50=0.4-4.3â µM). Cell cycle analysis demonstrated that 7 b and 7 c induce cell cycle arrest predominantly in the G1 phase. Both 7 b and 7c significantly inhibited migration of A375 melanoma cells; greater effects were demonstrated by 7 b. Molecular modelling analysis provides insight into a plausible mechanism of action.
Subject(s)
Antineoplastic Agents , Melanoma , Humans , Melanoma/metabolism , Cell Line, Tumor , Cell Proliferation , Apoptosis , Tamoxifen , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic useABSTRACT
Breast cancer has the second highest frequency of death rate among women worldwide. Early-stage prevention becomes complex due to reasons unknown. However, some typical signatures like masses and micro-calcifications upon investigating mammograms can help diagnose women better. Manual diagnosis is a hard task the radiologists carry out frequently. For their assistance, many computer-aided diagnosis (CADx) approaches have been developed. To improve upon the state of the art, we proposed a deep ensemble transfer learning and neural network classifier for automatic feature extraction and classification. In computer-assisted mammography, deep learning-based architectures are generally not trained on mammogram images directly. Instead, the images are pre-processed beforehand, and then they are adopted to be given as input to the ensemble model proposed. The robust features extracted from the ensemble model are optimized into a feature vector which are further classified using the neural network (nntraintool). The network was trained and tested to separate out benign and malignant tumors, thus achieving an accuracy of 0.88 with an area under curve (AUC) of 0.88. The attained results show that the proposed methodology is a promising and robust CADx system for breast cancer classification. Graphical Abstract Flow diagram of the proposed approach. Figure depicts the deep ensemble extracting the robust features with the final classification using neural networks.